Vital Chemtech Limited has informed the Exchange regarding Appointment of Mr Vivek Nathwani as Non- Executive Independent Director of the company w.e.f. May 30, 2025.
VITAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vital Chemtech Limited (NSE: VITAL) has disclosed the voting results of its 4th Annual General Meeting held on September 27, 2025, where all 10 resolutions were passed. The resolutions covered adoption of audited financial statements for FY25, re-appointment of Mrs. Sangeeta Vipul Bhatt, ratification of cost auditor remuneration, appointment of two new independent directors (Mr. Ajay Kumar Agrawal and Mr. Vivek Dinesh Nathwani), change in designation of Mrs. Sangeeta Bhatt from Whole Time Director to Non-Executive Director, approval of material related party transactions with Vital Chemicals and Vital Synthesis Limited for FY26, and approval of the Vital Employee Stock Option Scheme 2025 along with its extension to group company employees. Of the 2,131 shareholders on record date, 25 attended via video conferencing. Around 74.62% of total equity (1.78 crore shares) voted on most resolutions, with 100% support except for the ESOP resolutions, which received 99.58% support (1,200 votes against). The scrutinizer was SCS & Co. LLP (Anjali Sangtani).
Routine AGM business completed smoothly with near-unanimous shareholder approval, including a new ESOP scheme that could lead to future equity dilution and director additions that strengthen the board. The very low public participation (under 4% of non-promoter shares voted on RPTs) and zero dissent on most items signal strong promoter control with limited independent shareholder activism, which is typical for small-cap companies with concentrated ownership.